September 10, 2019 – Funding
A key goal of the 2019 Nodal Award Program is to encourage sustained collaboration through future submission of new multi-investigator grants that respond to NCI research priorities. Thus, Nodal Awards will seed work...
Funding
DF/HCC offers a variety of funding opportunities to members to encourage and enhance the collaborative spirit of research within the Harvard-affiliated medical community. Annual funding opportunities through DF/HCC have historically included pilot project awards through our Cancer Center development funding budget, SPORE career and project development awards, and jointly sponsored funding opportunities made available through our many partnerships with entities such as the Harvard Catalyst, the U54 DF/HCC UMass Boston Partnership, and the Harvard University Center for AIDs Research.
Two important funding programs have provided substantial opportunities to DF/HCC investigators recently. The Bridge Project, a collaboration between DF/HCC and the Koch Institute for Cancer Research at MIT, offers funding for teams that bring bioengineering, advanced cancer science, and clinical oncology together to address unmet clinical needs and technological solutions. The A. David Mazzone Research Awards Program funds a series of collaborative and innovative cancer research, career development, community outreach, and training projects to address a range of needs in prostate cancer and Lupron-treatable diseases.
Active Funding Opportunities
df/hcc & Harvard Community Funding opportunity | APPLICATION DEADLINE |
| Application due January 4, 2019 | |
| Harvard HIV T32 Training Funds | Application due February 1, 2019 |
| Application due February 15, 2019 |
External Funding Opportunity | Application Deadline |
| NCCN Taiho Trifluridine/Tipiracil Research Grant Opportunity | Application due January 7, 2019 |
| LOI due January 16, 2019 | |
| FNIH PACT RFA for Novel Biomarkers | Application due January 21, 2019 |
| DOD Joint Warfighter Medical Research Program (JWMRP) | Application due February 1, 2019 |
| LLS Specialized Center of Research Program | LOI due August 31, 2018; Application due February 15,2019 |
| Doris Duke 2019 Clinical Scientist Development Award | LOI due November 28, 2018; Application due March 22, 2019 |
| LOI due November 1, 2018; Application due April 8, 2019 |
NOTABLE NIH OPPORTUNITIES | Application Deadline |
LOI due December 11, 2018; Application due January 11, 2019 | |
| LOI Due January 26, 2019, Application due February 26, 2019 | |
| NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 Independent Clinical Trial Required) | LOI Due January 26, 2019, Application due February 26, 2019 |
| NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Required) | Application Due February 12, 2019 |
| NIH Pathway to Independence Award (Parent K99/R00 - Independent Clinical Trial Not Allowed) | Application Due February 12, 2019 |
Funding Opportunities & Archive
-
-
September 05, 2019 – Funding
Letter of intent due October 8, 2019; Full proposal due October 23, 2019
-
May 22, 2019
DF/HCC has been invited to nominate a candidate for the 2020 Pew-Stewart Scholars for Cancer Research Program award
-
April 19, 2019
The short-term goal of these supplements is to provide funding for centers to perform developmental and preclinical research that addresses specific challenges in cell-based immunotherapies.
-
April 16, 2019
The purpose of this joint grant between UMass Boston and DF/HCC is to foster and support intensive collaborations among investigators at UMass Boston (an institution that serves communities with cancer health...